AMYLYX

Amylyx is a Cambridge-based pharmaceutical company dedicated to the development of therapeutics for the treatment of neurodegenerative disorders. © Copyright 2023 Amylyx. All Rights Reserved... The below are only select criteria for the PHOENIX trial. For a list of the full eligibility criteria for the PHOENIX trial please visit www.clinicaltrials.gov (NCT05021536)... Learn about the A35-004 Study (PHOENIX) for adults with Amyotrophic Lateral Sclerosis (ALS).

Primary location: Cambridge United States